QIAGEN Companion Diagnostic Wins FDA Approval for use with IRESSA
therascreen® EGFR RGQ PCR Kit to guide treatment with AstraZeneca’s lung cancer drug in U.S.
therascreen® EGFR RGQ PCR Kit to guide treatment with AstraZeneca’s lung cancer drug in U.S.
QIAGEN Clinical Insight® bioinformatics offering allows clinical labs to interpret and report genomic variants will be demonstrated at upcoming ClinGen, ASCO and ESHG meetings
New service gives all researchers exclusive access to liquid biopsy-based tools
CN Bio supports R&D efforts via fast-track Drug Metabolism and Safety Toxicity Testing Services that deliver human translatable insights from lead candidates in a few weeks and at lower cost than animal studies. By accessing the Company’s expertise and advanced in vitro liver-on-chip models, these Services enable researchers to step beyond standard in-house laboratory workflows for better informed pre-clinical decisions.
High Quality Assays with Reproducible and Reliable Results
Sharad Menon discusses the intricacies of the drug purification process, the techniques his team uses to detect impurities and future trends in biologics testing
Patients with underlying heart problems are more than four times as likely to die from COVID-19
Guest editorial: Brice Ezzouaouy, Senior Product Manager, Beckman Coulter Life Sciences, outlines the challenges of dimly expressed markers and presents a solution